Literature DB >> 9039944

Development of ganciclovir resistance during treatment of primary cytomegalovirus infection after liver transplantation.

H R Rosen1, K G Benner, K D Flora, J M Rabkin, S L Orloff, A Olyaei, S Chou.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9039944     DOI: 10.1097/00007890-199702150-00026

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  6 in total

1.  Emergence of multiple human cytomegalovirus ganciclovir-resistant mutants with deletions and substitutions within the UL97 gene in a patient with severe combined immunodeficiency.

Authors:  D G Wolf; I Yaniv; S Ashkenazi; A Honigman
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

2.  Oral ganciclovir usage for cytomegalovirus prophylaxis in organ transplant recipients: is emergence of resistance imminent?

Authors:  N Singh; V L Yu
Journal:  Dig Dis Sci       Date:  1998-06       Impact factor: 3.199

Review 3.  New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients.

Authors:  I G Sia; R Patel
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

Review 4.  Current management strategies for the prevention and treatment of cytomegalovirus infection in pediatric transplant recipients.

Authors:  Javier Bueno; Carmen Ramil; Michael Green
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

5.  Lack of emergence of cytomegalovirus UL97 mutations conferring ganciclovir (GCV) resistance following preemptive GCV therapy in allogeneic stem cell transplant recipients.

Authors:  C Gilbert; J Roy; R Belanger; R Delage; C Beliveau; C Demers; G Boivin
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

6.  The Endothelin Receptor Antagonist Macitentan Inhibits Human Cytomegalovirus Infection.

Authors:  Natalia Landázuri; Jennifer Gorwood; Ylva Terelius; Fredrik Öberg; Koon Chu Yaiw; Afsar Rahbar; Cecilia Söderberg-Nauclér
Journal:  Cells       Date:  2021-11-08       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.